Summary
Applied cloud-based AI accelerators to scale quantum chemistry simulations in early drug discovery. Enhanced the speed and feasibility of high-accuracy molecular modeling, including protein–ligand interactions. Supported more efficient identification of novel drug candidates while evaluating the practical and economic viability of large-scale computational approaches.